Mechanism of Action

With Fluofarma Bioengineering, uncover the cellular Mechanism Of Action of your compounds and improve your chances of putting your next blockbuster on the market.

Benefits

Mechanism Of Action studies can impact your drug-discovery pipeline and commercial development strategy.
Indeed knowledge of the MOA will maximize your drug-discovery pipeline by optimizing your leads and improving their efficacy and safety profiles.
It will help you also to drive your drug safely to approval as it accelerates the proof-of-concept studies, enhances the toxicological assessment and allows the identification of unexpected mechanistic interaction.
Last but not the least, this study will add new values to your pipeline as you will be able to discover novel drug targets.

Signaling pathway analysis

Fluofarma's technologies help you visualize a drug's functional effects through the analysis of over 150 different molecular events. Up to 5 parameters can be monitored simultaneously allowing the study of a molecular target with its partners within a single experiment. In addition, over 40 different cellular models are available (including cell lines, primary cell cultures and 3D microtissue cultures) to provide you with the best MOA results.

Expertise

Our scientists, with extensive expertise in cell biology and cell signaling will design...new compounds, allowing you a deeper understanding of their mechanisms of action.

Fluofarma Bioengineering Division 

Fluofarma Bioengineering

Fluofarma Biocomputing Division

Breaking news

  • High Content Analysis 2012

    Fluofarma will be attending the High Content Analysis 2012 in San Francisco, from January 9th to 12th. We look forward to seeing you at our booth (n° 34) and your are welcome the 11th at the « Luncheon Technology Showcase: High-Content Data Analysis » where Fluofarma will present CytoSurfe®r. An innovative and intuitive software application for High content image analysis.

    Read more [+]

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal "The American Journal of Pathology".

    Read more [+]